Fujikawa K, Saito T, Kurose K, Kojima T, et al. Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors. PLoS One 2023;18:e0291772.
PMID: 37729184